Intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases.

Purpose: To investigate the short-term outcomes after intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases.

Methods: Thirty-four eyes of 29 patients with age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion (RVO) received a single dose intravitreal injection of 0.05 ml ziv-aflibercept (1.

Cohort profile: Shahroud Eye Cohort Study.

The Shahroud Eye Cohort Study was set up to determine the prevalence and incidence of visual impairment and major eye conditions in the 40-64-year-old population of Shahroud as a Middle Eastern population. The first phase of the study was conducted in 2009-10. Using random cluster sampling, 6311 Shahroud inhabitants were invited for ophthalmologic examinations; of these, 5190 participants completed phase 1 (participation rate of 82.

Ultrasound biomicroscopy study of vitreous incarceration subsequent to intravitreal injections.

Objective: To study the existence of vitreous incarceration by ultrasound biomicroscopy (UBM) at the pars plana after direct intravitreal injection of triamcinolone acetonide ± bevacizumab without anterior chamber paracentesis.

Design: Interventional case series.

Participants: Patients undergoing intravitreal injection of triamcinolone acetonide with or without intravitreal bevacizumab.